Therefore, immunohistochemistry (IHC) is necessary to confirm the tumor’s endothelial origin, with markers like CD31, CD34, FLI1, and ERG being particularly useful for identifying vascular differentiation (Figure 4) [4,12]. This evidence concerns the gene PECAM1 and neoplasm.